|Articles|September 17, 0001

Side effects preclude thalidomide usefulness for AMD

Philadelphia-Thalidomide is dead, at least when it comes to itscurative properties for age-related macular degeneration (AMD). This isthe conclusion of the Age-Related Macular Degeneration and Thalidomide Study(AMDATS).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME